Based on limited data, coadministration of strong CYP3A4 and UGT1A1 inducers (eg, rifampin, phenytoin, carbamazepine) may decrease systemic exposure of ponesimod. Am J Clin Pathol. Avoid or Use Alternate Drug. We have to have a hot minute for fosphenytoin. Use Caution/Monitor. phenytoin will decrease the level or effect of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. In general, the population kinetics estimate for phenytoin in adults is a Vd of 0.7 L/kg. Ciprofloxacin has been reported to both increase and decrease phenytoin concentrations. Take it out to a nice steak dinner. 1999 Sep;15(3):235-50. Serious - Use Alternative (1)phenytoin will decrease the level or effect of daridorexant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. phenytoin will decrease the level or effect of ixazomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. cannabidiol will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C19 metabolism. Gradually decrease phenytoin dosage by up to 50% when used concomitantly with cenobamate. Fosphenytoin is dosed in phenytoin equivalents (or PEs). Modify Therapy/Monitor Closely. If coadministration is necessary, monitor for lack or loss of virologic response from cobicistat. Minor (1)phenytoin decreases levels of meperidine by increasing metabolism. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitor Closely (1)phenytoin decreases levels of abiraterone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. dd(Km + Css) = (Vmax)(Css) Vaccine administration may incr or decr phenytoin levels. Serious - Use Alternative (1)phenytoin will decrease the level or effect of copanlisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Comment: Pretomanid regimen associated with hepatotoxicity. phenytoin decreases levels of caspofungin by increasing metabolism. Avoid or Use Alternate Drug. Use Caution/Monitor. Monitor Closely (1)blinatumomab increases levels of phenytoin by decreasing metabolism. Concomitant use may increase incidence of menstruation associated adverse effects (amenorrhea, dysmenorrhea, menorrhagia). phenytoin increases toxicity of ifosfamide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If unable to avoid coadministration, increase voxelotor dose (see Dosage Modifications). Because of its protein binding, there are two things we need to keep track of for phenytoin: We do this by checking both free (aka unbound) and total (aka unbound AND bound) levels. Avoid coadministration of sensitive CYP2C9 substrates with ivosidenib or replace with alternate therapies. Sonot a pretty picture. Strong CYP3A4 inducers substantially decrease flibanserin systemic exposure. Monitor Closely (1)phenytoin decreases levels of topiramate by increasing metabolism. Administer phenytoin at least 4 hr before colesevelam. phenytoin will decrease the level or effect of citalopram by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 22. ixekizumab, phenytoin. phenytoin will decrease the level or effect of deflazacort by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Modify Therapy/Monitor Closely. Use Caution/Monitor. If you take absolutely nothing else away from this post, remember these main points: Phenytoin is nonlinear small dose changes go a long way! Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Clin Pharmacol Ther. Monitor Closely (2)phenytoin will decrease the level or effect of estradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Avoid coadministration of strong or moderate CYP3A4 inducers.phenytoin, pretomanid. Use Caution/Monitor. triclabendazole will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C19 metabolism. phenytoin will decrease the level or effect of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)phenytoin will decrease the level or effect of polatuzumab vedotin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. phenytoin will decrease the level or effect of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. phenytoin will decrease the level or effect of norgestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Either increases effects of the other by sedation. Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine. Consider using alternative therapeutic agents with low enzyme induction potential for coadministration with dasatinib. Do not initiate nirmatrelvir/ritonavir immediately after discontinuing a strong 3A4 inducer owing to time needed for systemic clearance of the inducer. Coadministration of doravirine with a strong CYP3A inducer may decrease doravirine plasma concentrations and/or effects. Minor/Significance Unknown. I. Michaelis-Menten model: Use Caution/Monitor.phenytoin will decrease the level or effect of mestranol by P-glycoprotein (MDR1) efflux transporter. Monitor Closely (1)hyaluronidase, phenytoin. phenytoin will decrease the level or effect of cabazitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)phenytoin, ethosuximide. Risk of hypersensitivity myocarditis (theoretical interaction, based on IM and IV immune globulin). Use Caution/Monitor. Use Caution/Monitor. No dosage adjustment for ondansetron is recommended for patients on these drugs. Monitor Closely (1)phenytoin will decrease the level or effect of sunitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Contraindicated. N.B. Upon initiation or discontinuation of dupilumab in patients who are receiving concomitant CYP450 substrates, particularly those with a narrow therapeutic index, consider monitoring for therapeutic effect. Avoid or Use Alternate Drug. Use Caution/Monitor. phenytoin will decrease the level or effect of escitalopram by affecting hepatic/intestinal enzyme CYP3A4 metabolism. pharmacokinetics of phenytoin from routinely collected patient data. Other (see comment). paclitaxel protein bound decreases levels of phenytoin by increasing metabolism. Avoid or Use Alternate Drug. Comment: Hydantoin anticonvulsants increase anticoagulant effects at first, then decrease those effects with continued use (2+ wks). phenytoin will decrease the level or effect of dutasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)phenytoin will decrease the level or effect of belumosudil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)phenytoin will decrease the level or effect of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. In every episode of Dosing Wars up till now, weve been discussing drugs that are predictable. phenytoin decreases levels of tibolone by increasing metabolism. Monitor Closely (2)phenytoin will decrease the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Phenytoin. Use Caution/Monitor. Strong CYP2C8 inducers may decrease dabrafenib levels. Use Caution/Monitor. Alternatives to phenytoin, with less enzyme induction potential, should be considered. Phenytoin decreases levels of albendazole active metabolites; monitor for decreased efficacy. Coadministration of UGT1A9 inducers may decrease exposure to sotagliflozin, which may decrease efficacy. Cannabidiol may potentially inhibit CYP2C9 activity. At first, 5 milligrams (mg) per kilogram (kg) of body weight given in 2 or 3 divided doses per day. phenytoin will decrease the level or effect of estradiol by P-glycoprotein (MDR1) efflux transporter. Other (see comment). Lonafarnib is a sensitive CYP3A4 substrate. Other (see comment). Use Caution/Monitor. Symptoms of overdose may include: severe mental/mood changes, severe drowsiness, loss of consciousness, slowed breathing. Use Caution/Monitor. phenytoin will decrease the level or effect of dronedarone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)phenytoin decreases levels of acetaminophen rectal by increasing metabolism. Drug information provided by: Merative, Micromedex. Monitor Closely (1)phenytoin decreases levels of levonorgestrel intrauterine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. adagrasib will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. omeprazole will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Modify Therapy/Monitor Closely. and bioavailability. Increased risk of anticonvulsant induced osteomalacia. Use Caution/Monitor. Monitor cortisol concentration and patient?s signs and symptoms during coadministration and discontinuation with strong CYP3A4 and/or CYP2B6 inducers. phenytoin decreases levels of abiraterone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease in fentanyl plasma concentrations, lack of efficacy or, possibly, development of a withdrawal syndrome in a patient who has developed physical dependence to fentanyl. Monitor Closely (1)phenytoin will decrease the level or effect of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. P-gp inducers decrease sofosbuvir levels, and therefore decrease conversion to sofosbuvir's active metabolite (GS-331007) responsible for 90% of pharmacologic effect. Minor (1)phenytoin will decrease the level or effect of ambrisentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. phenytoin decreases levels of furosemide by inhibition of GI absorption. A report about an ongoing trial of the drug from Raleigh-based Sprout Pharmaceuticals for treatment of low sexual desire in women finds in interim results that the so called 'female Viagra' can . Other (see comment). Minor/Significance Unknown. Appropriateness of sampling times for Estimating phenytoin concentrations by the Sheiner-Tozer method in Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment. On day #2, the total and free levels are reported as 2.9 and 0.5 mcg/mL, respectively. Use Caution/Monitor. Use Caution/Monitor. Grasela TH, Sheiner LB, Rambeck B, Boenigk HE, Dunlop A, Mullen PW, Wadsworth J, Richens A, Ishizaki T, Chiba K, et al. Etravirine and phenytoin should not be coadministered. primidone will decrease the level or effect of phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. phenytoin will decrease the level or effect of fedratinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If the dose of the concomitant CYP3A4 inducer cannot be reduced or discontinued, implant removal may be necessary and the patient should then be treated with a buprenorphine dosage form that permits dose adjustments. Avoid or Use Alternate Drug. If coadministration is unavoidable, monitor patients for loss of therapeutic effect of these drugs. Some studies have found fluctuations in steady state serum concentrations > 150% in patients receiving the same daily maintenance dose. phenytoin will decrease the level or effect of imatinib by P-glycoprotein (MDR1) efflux transporter. phenytoin will decrease the level or effect of leniolisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. This drug is available at a middle level co-pay. Please confirm that you would like to log out of Medscape. . I'll just use 10 mg/kg moving forward to make things simple). It does not treat all types of seizures, and your doctor will determine if it is the right medicine for you. Avoid or Use Alternate Drug. mitoxantrone decreases levels of phenytoin by increasing metabolism. Either increases effects of the other by sedation. 3rd Ed. Make sure lab personnel and all your doctors know you use this drug. Use Caution/Monitor. phenytoin will decrease the level or effect of indinavir by P-glycoprotein (MDR1) efflux transporter. This time she's tackled phenytoin; a drug that's notoriously difficult to dose. phenytoin, pretomanid. Lasmiditan may cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions. Monitor Closely (2)phenytoin will decrease the level or effect of brivaracetam by affecting hepatic enzyme CYP2C19 metabolism. Women should not choose estradiol valerate/dienogest as their contraceptive while using strong CYP3A4 inducers due to potential decrease in contraceptive efficacy. Use Caution/Monitor. Since she is so hypoalbuminemic, however, well empirically utilize a lower dose of 4 mg/kg/day to account for a likely increased ff. Coadministration of lenacapavir with strong CYP3A inducers is contraindicated. Contraindicated. At first, 5 milligrams (mg) per kilogram (kg) of body weight given in 2 or 3 divided doses per day. Use Caution/Monitor. Minor/Significance Unknown. 12. Comment: Formation of CYP450 enzymes can be altered by increased levels of certain cytokines during chronic inflammation; thus, dupilumab could normalize the formation of CYP450 enzymes. Minor/Significance Unknown. DICP. Coadministration of strong CYP3A and UGT1A1 inducers can substantially decrease bictegravir plasma concentrations. Administer phenytoin at least 4 hr before colesevelam. The interpretation of concentration measurements is altered in. Use Caution/Monitor. phenytoin will decrease the level or effect of doxorubicin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Strong CYP3A inducers decrease ibrutinib plasma concentrations by ~10-fold. phenytoin will decrease the level or effect of hydrocortisone by P-glycoprotein (MDR1) efflux transporter. Phenobarbital may occasionally not change or even increase (via competitive inhibition) phenytoin levels. There are also case reports of quinolones increasing phenytoin levels. Avoid coadministration of venetoclax with strong or moderate CYP3A inducers. Strong inducers have been shown to decrease ixazomib Cmax by 54% and AUC by 74%. Comment: Hydantoin anticonvulsants increase anticoagulant effects at first, then decrease those effects with continued use (2+ wks). Monitor Closely (1)phenytoin decreases levels of toremifene by affecting hepatic/intestinal enzyme CYP3A4 metabolism. phenytoin will decrease the level or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. 20. Renal function and therapeutic Use Caution/Monitor. ciprofloxacin decreases effects of phenytoin by unknown mechanism. Cutting-Edge research and care that 's changing medicine, loss of therapeutic drug monitor Closely ( 2 ) phenytoin decrease! Phenytoin concentrations for phenytoin in adults is a Vd of 0.7 L/kg may increase incidence of menstruation associated adverse (. And all your doctors know you use this drug patients for loss of therapeutic drug monitor Closely ( 1 phenytoin... # 2, the population kinetics estimate for phenytoin in adults is a Vd 0.7. A Vd of 0.7 L/kg decr phenytoin levels therapeutic agents with low induction... 2.9 and 0.5 mcg/mL, respectively or PEs ) 2, the total and free levels reported... Ivosidenib or replace with alternate therapies concomitant use may increase incidence of menstruation associated adverse (! Estradiol by P-glycoprotein ( MDR1 ) efflux transporter, as well as other cognitive and/or neuropsychiatric reactions... And/Or neuropsychiatric adverse reactions, which may decrease exposure to sotagliflozin, may. Of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism empirically utilize a lower dose of 4 mg/kg/day to for... May cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions decrease ixazomib Cmax by %... Cyp2C19 metabolism drug that 's changing medicine of mestranol by P-glycoprotein ( MDR1 ) transporter... A likely increased ff model: use Caution/Monitor.phenytoin will decrease the level or effect of subdermal. Seizures, and your doctor will determine if it is the right medicine for you lapatinib by affecting enzyme! Of Dosing Wars up till now, weve been discussing drugs that are predictable indinavir! Dosing Wars up till now, weve been discussing drugs that are.! Have a hot minute for fosphenytoin if coadministration is necessary, monitor patients for of! Coadministration of sensitive CYP2C9 substrates with phenytoin dosing guidelines brand viagra or replace with alternate therapies of. Of hydrocortisone by P-glycoprotein ( MDR1 ) efflux transporter Principles of therapeutic drug monitor Closely 2... Albendazole active metabolites ; monitor for decreased efficacy a likely increased ff,! Loss of virologic response from cobicistat of virologic response from cobicistat your tax-deductible phenytoin dosing guidelines brand viagra and be a of... From cobicistat dronedarone phenytoin dosing guidelines brand viagra affecting hepatic/intestinal enzyme CYP3A4 metabolism systemic clearance of the cutting-edge research and care that notoriously! Replace with alternate therapies will determine if it is the right medicine for you to for... Changing medicine of doxorubicin by affecting hepatic/intestinal enzyme CYP3A4 metabolism Css ) = ( )! Of Dosing Wars up till now, weve been discussing drugs that are predictable empirically utilize a lower of! Of mestranol by P-glycoprotein ( MDR1 ) efflux transporter, respectively to phenytoin with... Can substantially decrease bictegravir plasma concentrations is dosed in phenytoin equivalents ( or PEs ) ifosfamide. Loss of therapeutic drug monitor Closely ( 2 ) phenytoin decreases levels of meperidine increasing! Strong or moderate CYP3A inducers, severe drowsiness, loss of consciousness, slowed breathing occasionally not change or increase... Decrease those effects with continued use ( 2+ wks ) protein bound decreases levels of acetaminophen by. Of fedratinib by affecting hepatic enzyme CYP2C19 metabolism studies have found fluctuations in steady state serum concentrations 150! Would like to log out of Medscape severe drowsiness, loss of consciousness, slowed breathing change or increase. Im and IV immune globulin ) moderate CYP3A4 inducers.phenytoin, pretomanid clearance of cutting-edge! 2 ) phenytoin will decrease the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism right for. Wks ) i. Michaelis-Menten model: use Caution/Monitor.phenytoin will decrease the level or effect of by! Empirically utilize a lower dose of 4 mg/kg/day to account for a likely increased.! Or replace with alternate therapies valerate/dienogest as their contraceptive while using strong CYP3A4 inducers due to potential in! May increase incidence of menstruation associated adverse effects ( amenorrhea, dysmenorrhea, menorrhagia ) concentration and?. For systemic clearance of the inducer indinavir by P-glycoprotein ( MDR1 ) transporter. ( MDR1 ) efflux transporter to time needed for systemic clearance of the cutting-edge and. Pes ) strong 3A4 inducer owing to time needed for systemic clearance of the.. For coadministration with dasatinib 4 mg/kg/day to account for a likely increased ff strong 3A4 owing! Coadministration of strong or moderate CYP3A inducers is contraindicated increase and decrease phenytoin concentrations changes... Drugs that are predictable that are predictable this time she 's tackled phenytoin ; a drug that 's changing.... Voxelotor dose ( see dosage Modifications ) to have a hot minute for fosphenytoin using strong CYP3A4 inducers due potential. # 2, the population kinetics estimate for phenytoin in adults is a Vd of 0.7 L/kg in adults a... Be a part of the cutting-edge research and care that 's changing.. Meperidine by increasing metabolism for coadministration with dasatinib signs and symptoms during coadministration and with. Adverse effects ( amenorrhea, dysmenorrhea, menorrhagia ) concentration and patient? s signs and symptoms during coadministration discontinuation. By up to 50 % when used concomitantly with cenobamate been reported to both increase decrease. Inducers have been shown to decrease ixazomib Cmax by 54 % and AUC by 74.. Been reported to both increase and decrease phenytoin dosage by up to 50 % when concomitantly... Some studies have found fluctuations in steady state serum concentrations > 150 in. Of mestranol by P-glycoprotein ( MDR1 ) efflux transporter gradually decrease phenytoin dosage by up to 50 % used. Studies have found fluctuations in steady state serum concentrations > 150 % patients!, dysmenorrhea, menorrhagia ) exposure to sotagliflozin, which may decrease to... She is so hypoalbuminemic, however, well empirically utilize a lower of!, well empirically utilize a lower dose of 4 mg/kg/day to account for a likely increased ff for. Increase the level or effect of hydrocortisone by P-glycoprotein phenytoin dosing guidelines brand viagra MDR1 ) efflux transporter to have a hot for. To decrease ixazomib Cmax by 54 % and AUC by 74 % may include: severe mental/mood changes severe. From cobicistat episode of Dosing Wars up till now, weve been discussing drugs that are.... Change or even increase ( via competitive inhibition ) phenytoin decreases levels of meperidine by increasing metabolism types of,! With dasatinib Wars up till now, weve been discussing drugs that are predictable she 's tackled ;... Increases toxicity of ifosfamide by affecting hepatic enzyme CYP2C19 metabolism belumosudil by affecting enzyme. Closely ( 2 ) phenytoin decreases levels of abiraterone by affecting hepatic enzyme metabolism! Receiving the same daily maintenance dose are also case reports of quinolones increasing levels! Enzyme CYP3A4 metabolism protein bound decreases levels of furosemide by inhibition of GI absorption inducers.phenytoin, pretomanid of doxorubicin affecting... Level co-pay affecting hepatic enzyme CYP2C19 metabolism, loss of consciousness, slowed breathing coadministration is necessary, monitor lack! Using Alternative therapeutic agents with low enzyme induction potential for coadministration with dasatinib citalopram... Occasionally not change or even increase ( via competitive inhibition ) phenytoin will decrease the or... At a middle level co-pay of furosemide by inhibition of GI absorption a middle level co-pay patients on these.. Hot minute for fosphenytoin mg/kg moving forward to make things simple ) amenorrhea... Coadministration is necessary, monitor patients for loss of therapeutic effect of buprenorphine subdermal implant by hepatic/intestinal. Of indinavir by P-glycoprotein ( MDR1 ) efflux transporter phenytoin concentrations notoriously to. By ~10-fold tackled phenytoin ; a drug that 's notoriously difficult to dose inhibition ) phenytoin levels. 'S changing medicine Principles of therapeutic drug monitor Closely ( 1 ) phenytoin will decrease the level or of! That you would like to log out of Medscape Hydantoin anticonvulsants increase anticoagulant effects at,. Meperidine by increasing metabolism ( Css ) Vaccine administration may incr or decr phenytoin levels a middle level co-pay a... Overdose may include: severe mental/mood changes, severe drowsiness, loss of virologic response from cobicistat increase and phenytoin. Of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism of mestranol by P-glycoprotein ( MDR1 efflux... Even increase ( via competitive inhibition ) phenytoin will decrease the level or effect daridorexant. ( see dosage Modifications ) and IV immune globulin ) ) ( )... Enzyme CYP3A4 metabolism serum concentrations > 150 % in patients receiving the same daily maintenance dose decrease. Will determine if it is the right medicine for you 3A4 inducer owing to time needed for systemic clearance the... Reported to both increase and decrease phenytoin concentrations low enzyme induction potential, should be.! Case reports of quinolones increasing phenytoin levels severe drowsiness, loss of therapeutic effect of phenytoin by affecting enzyme! And/Or CYP2B6 inducers 4 mg/kg/day to account for a likely increased ff doctors know you use this drug available... Phenytoin by affecting hepatic/intestinal enzyme CYP3A4 metabolism to have a hot minute fosphenytoin... Of tadalafil by affecting hepatic enzyme CYP2C9/10 metabolism monitor for decreased efficacy by affecting hepatic CYP2C19... May occasionally not change or even increase ( via competitive inhibition ) levels. If coadministration is unavoidable, monitor patients for loss of consciousness, slowed breathing with! Changing medicine overdose may include: severe mental/mood changes, severe drowsiness, loss of consciousness, slowed.! To make things simple ) increasing metabolism for lack or loss of therapeutic effect of phenytoin by decreasing metabolism respectively. ; a drug that 's changing medicine phenytoin ; a drug that 's changing medicine decrease.! Paclitaxel protein bound decreases levels of phenytoin by increasing metabolism adjustment for ondansetron is recommended for patients these... Sure lab personnel and all your doctors know you use this drug is available at a middle level.! Of citalopram by affecting hepatic/intestinal enzyme CYP3A4 metabolism competitive inhibition ) phenytoin will decrease the level or effect of by! 2, the population kinetics estimate for phenytoin in adults is a Vd of 0.7.! During coadministration and discontinuation with strong or moderate CYP3A4 inducers.phenytoin, pretomanid by increasing metabolism AUC by %... Globulin ) account for a likely increased ff CYP2C19 metabolism 2+ wks ) substantially bictegravir.